targeted drug delivery
| 3 min read
A novel eye drop from LENZ Therapeutics represents the first time the FDA has approved aceclidine, a cholinergic agonist, in any drug.
| 4 min read
A well-chosen CDx development partner can streamline drug development, reduce delays, and pave the way for successful regulatory approval and market entry.
| 8 min read
Explore how suprachoroidal injection is a groundbreaking new macular degeneration treatment. Learn how it offers a safer, more targeted alternative to a traditional subretinal injection.
| 3 min read
Genetically modified stem cells show promise in a targeted approach to taming inflammation in autoimmune diseases.
Available on Demand
Innovative carriers and delivery strategies may improve gene therapy efficacy and safety.
Page 1 of 1 - 5 Total Items
